Gilead gets 2nd HIV drug approved for PrEP, but its own Truvada may be hard to dethrone


Although Descovy showed an advantageous side-effect profile, one doctor described Truvada as mostly well-tolerated, while another said switching to Descovy will depend on insurance coverage. Both expressed a desire for data in other vulnerable populations.